[Duodenogastric reflux. Pharmacologic bases of medical treatment].
D000863:Antacids / Q000494:pharmacology; D001647:Bile Acids and Salts / Q000037:antagonists & inhibitors*; D002792:Cholestyramine Resin / Q000494:pharmacology / Q000627:therapeutic use; D004383:Duodenogastric Reflux / Q000150:complications / Q000188:drug therapy*; D005769:Gastrointestinal Motility / Q000187:drug effects; D006633:Histamine Antagonists / Q000494:pharmacology; D006801:Humans; D011954:Receptors, Dopamine / Q000187:drug effects; D013392:Sucralfate / Q000494:pharmacology; D014580:Ursodeoxycholic Acid / Q000494:pharmacology
D000863:Antacids; D001647:Bile Acids and Salts; D006633:Histamine Antagonists; D011954:Receptors, Dopamine; D002792:Cholestyramine Resin; D013392:Sucralfate; D014580:Ursodeoxycholic Acid
Reflux duodéno-gastrique. Bases pharmacologiques d'un traitement médical.